Price Alert

Astellas Pharma Inc. (ALPMF)

OTC: ALPMF · Real-Time Price · USD

11.10

0.00 (0.00%)

At close: Aug 08, 2025, 2:03 PM

Astellas Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	188.37B	179.87B	292.99B	302.93B	335.69B	253.98B	333.99B	561.49B	376.84B	381.82B	361.07B	313.01B	315.99B	350.21B	318.3B	301.92B	326.13B	306.51B	286.73B	239.93B
Short-Term Investments	29.94B	n/a	36.26B	n/a	28.78B	31.46B	29.66B	41.33B	19.78B	31.48B	31.95B	23.75B	21.3B	17.88B	9.99B	4.08B	5.56B	19.97B	7.7B	4.59B
Long-Term Investments	18.99B	19.15B	169.67B	19.48B	144.42B	85.75B	88.98B	142.97B	90.79B	71.22B	70.32B	146.19B	141.21B	144.74B	137.32B	95.5B	97.41B	98.04B	83.59B	82.28B
Other Long-Term Assets	153.25B	251.71B	1M	218.86B	18.6B	60.87B	60.07B	1M	54.24B	67.19B	70.46B	1M	-1M	-1M	n/a	46.56B	49.4B	63.86B	51.92B	48.91B
Receivables	632.52B	644.63B	558.27B	587.67B	534.99B	495.96B	487.89B	462.5B	427.96B	451.27B	452.49B	438.41B	382.46B	373.92B	357.8B	364.23B	343.18B	345.61B	332.73B	360.72B
Inventory	297.26B	287.34B	260.21B	256.05B	248.74B	225.98B	213.65B	200.22B	174.39B	163.22B	168.64B	164.83B	153.07B	151.58B	148.73B	157.25B	164.08B	155.74B	155.74B	155.07B
Other Current Assets	53.25B	92.07B	55.27B	94.02B	75.32B	74.18B	81.22B	93.24B	70.76B	76.28B	76.95B	73.03B	71.83B	63.62B	51.63B	45.31B	39.2B	55.43B	44.7B	40.26B
Total Current Assets	1,201.3B	1,203.9B	1,203B	1,240.7B	1,194.7B	1,050.1B	1,116.8B	1,317.5B	1,050B	1,072.6B	1,059.1B	989.28B	923.35B	939.33B	876.45B	868.72B	872.59B	863.29B	819.9B	795.98B
Property-Plant & Equipment	328.92B	332.72B	315.35B	309.69B	293.74B	289.03B	296.56B	290.78B	286.46B	269.11B	280.55B	280.18B	269.04B	267.82B	266.67B	269.7B	264.62B	255.18B	265.67B	267.11B
Goodwill & Intangibles	1,538.9B	1,644.1B	1,721B	1,946.8B	1,872.5B	1,840.3B	1,936.4B	946.11B	890.91B	940.61B	1,006.7B	974.09B	926.46B	945.9B	925.97B	914.44B	935.44B	964.96B	960.7B	1,006.3B
Total Long-Term Assets	2,138.2B	2,247.7B	2,259.2B	2,494.8B	2,374.9B	2,318.6B	2,426.3B	1,480.5B	1,406.6B	1,441.4B	1,524.5B	1,492.6B	1,409B	1,416.9B	1,385.1B	1,380.7B	1,401B	1,433.5B	1,417.1B	1,460.1B
Total Assets	3,339.5B	3,451.6B	3,462.2B	3,735.5B	3,569.6B	3,368.7B	3,543B	2,798B	2,456.5B	2,513.9B	2,583.7B	2,481.8B	2,332.4B	2,356.2B	2,261.5B	2,249.5B	2,273.6B	2,296.8B	2,237B	2,256B
Account Payables	187.84B	204.31B	161.17B	173.15B	185.19B	150.43B	147.25B	138.44B	140.24B	134.24B	146.53B	152.22B	130.74B	136.89B	111.57B	108.45B	124.78B	111B	113.51B	132.65B
Deferred Revenue	n/a	n/a	n/a	n/a	38.52B	149.3B	142.67B	133.86B	-88.55B	n/a	n/a	n/a	-157.73B	n/a	n/a	n/a	-136.1B	n/a	n/a	n/a
Short-Term Debt	266.53B	329.85B	307.26B	549.6B	487.22B	407.18B	416.56B	309B	75B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	572.69B	618.4B	588.89B	651.07B	443.13B	446.81B	455.78B	410.19B	366.98B	571.67B	614.88B	588.32B	420.12B	461.08B	443.2B	473.13B	342.7B	524.85B	503.42B	515.02B
Total Current Liabilities	1,061.6B	1,152.6B	1,093.4B	1,373.8B	1,285.7B	1,153.7B	1,162.3B	991.49B	726.03B	705.9B	761.41B	740.54B	687.41B	597.98B	554.77B	581.58B	592.37B	635.85B	616.93B	647.67B
Long-Term Debt	564.89B	585.51B	620.24B	443.06B	449.94B	465.95B	475.35B	50B	50B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	194.43B	219.75B	195.18B	242.2B	96.44B	112.01B	133.05B	46.1B	172.53B	237.62B	172.73B	46.6B	45.73B	48.18B	43.08B	285.01B	295.14B	292.39B	290.45B	301.68B
Total Long-Term Liabilities	764.68B	805.26B	839.04B	685.26B	687.89B	711.71B	741.42B	228.05B	222.53B	237.62B	172.73B	202.25B	184.68B	291.98B	289.12B	285.01B	295.14B	292.39B	290.45B	301.68B
Total Liabilities	1,826.3B	1,957.8B	1,932.4B	2,059.1B	1,973.6B	1,865.4B	1,903.7B	1,219.5B	948.56B	943.52B	934.14B	942.79B	872.09B	889.95B	843.89B	866.59B	887.51B	928.23B	907.39B	949.35B
Total Debt	831.43B	915.36B	927.5B	992.66B	1,005.7B	870.98B	889.61B	359B	200.01B	148.74B	82.39B	111.62B	212.74B	201.53B	204.84B	201.36B	278.26B	1.25B	2.75B	2.82B
Common Stock	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B	103B
Retained Earnings	740.94B	654.06B	817.61B	783.78B	809.4B	838.62B	884.51B	884.53B	908.16B	996.25B	1,003.6B	924.98B	944.26B	999.64B	985.23B	945.96B	953.29B	963.01B	941.85B	918.89B
Comprehensive Income	n/a	590.22B	n/a	645.6B	533.3B	412.8B	504.1B	444.72B	340.64B	313.61B	386.12B	355.4B	247.51B	200.13B	166.46B	171.91B	265.45B	132.14B	114.64B	115.03B
Shareholders Equity	1,513.3B	1,493.8B	1,529.8B	1,676.4B	1,596B	1,503.3B	1,639.3B	1,578.4B	1,508B	1,570.4B	1,649.5B	1,539.1B	1,460.3B	1,466.3B	1,417.6B	1,382.9B	1,386.1B	1,368.6B	1,329.6B	1,306.7B
Total Investments	18.99B	19.15B	123.04B	19.48B	144.42B	117.21B	118.64B	110.5B	110.58B	102.7B	102.27B	106.02B	101.88B	104.31B	95.67B	99.57B	102.97B	118B	91.29B	86.87B